Citations (37)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
I. Wilhelmsen & A. Berstad. (2004) Reduced relapse rate in duodenal ulcer disease leads to normalization of psychological distress: twelve‐year follow‐up. Scandinavian Journal of Gastroenterology 39:8, pages 717-721.
Read now
Read now
P. Bytzer, C. Aalykke, S. Rune, L. Weywadt, T. Gjørup, J. Eriksen, O. Bonnevie, C. Bekker, H. Kromann-Andersen, J. Kjærgaard, J. Rask-Madsen, M. Vilien, J. Hansen, T. Justesen, M. Vyberg, P. Stubbe Teglbjærg. (2000) Eradication of Helicobacter pylori Compared with Long-Term Acid Suppression in Duodenal Ulcer Disease: A Randomized Trial with 2-Year Follow-up. Scandinavian Journal of Gastroenterology 35:10, pages 1023-1032.
Read now
Read now
J. P. GISBERT, J. M. PAJARES, R. GARCÍA-VALRIBERAS, V. ABRAIRA, D. BOIXEDA, R. GARCÍA-GRÁVALOS, C. MARTÍN-DE-ARGILA, A. GARCÍA-PLAZA. (1998) Recurrence of Helicobacter pylori Infection after Eradication: Incidence and Variables Influencing It. Scandinavian Journal of Gastroenterology 33:11, pages 1144-1151.
Read now
Read now
S. HONDA, T. FUJIOKA, M. TOKIEDA, T. GOTOH, A. NISHIZONO, M. NASU. (1998) Gastric Ulcer, Atrophic Gastritis, and Intestinal Metaplasia Caused by Helicobacter pylori Infection in Mongolian Gerbils. Scandinavian Journal of Gastroenterology 33:5, pages 454-460.
Read now
Read now
I. Wilhelmsen. (1996) Quality of Life and Helicobacter pylori Eradication. Scandinavian Journal of Gastroenterology 31:sup221, pages 18-20.
Read now
Read now
H. Glise, B. Hallerbäck & I. Wiklund. (1996) Quality of Life: a Reflection of Symptoms and Concerns. Scandinavian Journal of Gastroenterology 31:sup221, pages 14-17.
Read now
Read now
J. Labenz, B. Tillenburg, U. Peitz & G. Borsch. (1996) Long-term Consequences of Helicobacter pylori Eradication: Clinical Aspects. Scandinavian Journal of Gastroenterology 31:sup215, pages 111-115.
Read now
Read now
I. Wilhelmsen. (1995) Quality of Life in Upper Gastrointestinal Disorders. Scandinavian Journal of Gastroenterology 30:sup211, pages 21-25.
Read now
Read now
Articles from other publishers (29)
Rodrigo Buzinaro Suzuki, Rodrigo Augusto Basso Lopes, George Arouche da Câmara Lopes, Tin Hung Ho & Márcia Aparecida Sperança. (2013) Low Helicobacter pylori primary resistance to clarithromycin in gastric biopsy specimens from dyspeptic patients of a city in the interior of São Paulo, Brazil. BMC Gastroenterology 13:1.
Crossref
Crossref
Javier P. Gisbert, M.D.. (2005) The Recurrence of Helicobacter pylori Infection: Incidence and Variables Influencing It. A Critical Review. The American Journal of Gastroenterology 100:9, pages 2083-2099.
Crossref
Crossref
Monique M Gerrits, Egbert-Jan van der Wouden, Dorine A Bax, Anton A van Zwet, Arnoud HM van Vliet, Albertine de Jong, Johannes G Kusters, Jaap C Thijs & Ernst J Kuipers. (2004) Role of the rdxA and frxA genes in oxygen-dependent metronidazole resistance of Helicobacter pylori. Journal of Medical Microbiology 53:11, pages 1123-1128.
Crossref
Crossref
Audun Berstad & Per Brandtzaeg. 2003. International Handbook of Foodborne Pathogens. International Handbook of Foodborne Pathogens.
Monique M. Gerrits, Marcel R. de Zoete, Niek L. A. Arents, Ernst J. Kuipers & Johannes G. Kusters. (2002)
16S rRNA Mutation-Mediated Tetracycline Resistance in
Helicobacter pylori
. Antimicrobial Agents and Chemotherapy 46:9, pages 2996-3000.
Crossref
Crossref
Javier P. Gisbert, Isabel García Arata, Daniel Boixeda, Mercedes Barba, Rafael Cantón, Antonio García Plaza & José María Pajares. (2002) Role of partner's infection in reinfection after Helicobacter pylori eradication. European Journal of Gastroenterology & Hepatology 14:8, pages 865-871.
Crossref
Crossref
D. Boixeda de Miquel & C. Martín de Argila. (2002) Tratamiento actual de la infección por Helicobacter pylori en la enfermedad ulcerosa péptica (primera parte). Revista Clínica Española 202:9, pages 492-494.
Crossref
Crossref
Egbert-Jan van der Wouden, Jacob C. Thijs, Anton A. van Zwet & Jan H. Kleibeuker. (2001) Six-year follow-up after successful triple therapy for Helicobacter pylori infection in patients with peptic ulcer disease. European Journal of Gastroenterology & Hepatology 13:10, pages 1235-1239.
Crossref
Crossref
H. J. O’Connor, C. Stewart, R. Walsh, C. N. McGee & B. Flynn. (2001) Six-year follow-up afterHelicobacter pylori eradication in peptic ulcer disease. Irish Journal of Medical Science 170:1, pages 24-27.
Crossref
Crossref
Harry H‐X Xia, Nghl Phung, Jamshid S Kalantar & Nicholas J Talley. (2000)
Demographic and endoscopic characteristics of patients with
Helicobacter pylori
positive and negative peptic ulcer disease
. Medical Journal of Australia 173:10, pages 515-519.
Crossref
Crossref
Xia, Kalantar, Mitchell & Talley. (2001)
Can
Helicobacter pylori
serology still be applied as a surrogate marker to identify peptic ulcer disease in dyspepsia?
. Alimentary Pharmacology & Therapeutics 14:5, pages 615-624.
Crossref
Crossref
Hans‐Gerd DammannUlrich R. FölschEckhart G. Hahn, Detlef‐Hasso Von KleistHans‐Ulrich KlörThomas KirchnerSonja Strobel & Manfred Kist. (2001)
Eradication of
H. pylori
with Pantoprazole, Clarithromycin, and Metronidazole in Duodenal Ulcer Patients: A Head‐to‐Head Comparison Between Two Regimens of Different Duration
. Helicobacter 5:1, pages 41-51.
Crossref
Crossref
Joshua J. Ofman, Jeff Etchason, William Alexander, Beth R. Stevens, Jeph Herrin, Charles Cangialose, David J. Ballard, Dale Bratzler, Kurtis S. Elward, Dawn FitzGerald, Joan Culpepper-Morgan & Barry Marshall. (2000) The quality of care for medicare patients with peptic ulcer disease. The American Journal of Gastroenterology 95:1, pages 106-113.
Crossref
Crossref
Včev, Štimac, Ivandić, Včeva, Takač & Pezerović. (2000)
Pantoprazole, amoxycillin and either azithromycin or clarithromycin for eradication of
Helicobacter pylori
in duodenal ulcer
. Alimentary Pharmacology & Therapeutics 14:1, pages 69-72.
Crossref
Crossref
Aleksandar Vc˘ev~, Davor Štimac, Andrijana Vc˘eva, Boris Takac˘, Davorin Pezerovíc & Ante Ivandíc. (2001)
High Dose Omeprazole Plus Amoxicillin and Azithromycin in Eradication of
Helicobacter pylori
in Duodenal Ulcers
. Helicobacter 4:1, pages 54-57.
Crossref
Crossref
Nayoung Kim, Seon Hee Lim, Kye Heui Lee, Hyun Chae Jung, &NA; Sung Song & Chung Yong Kim. (1998) Helicobacter pylori Reinfection Rate and Duodenal Ulcer Recurrence in Korea. Journal of Clinical Gastroenterology 27:4, pages 321-326.
Crossref
Crossref
Romuald J Adamek & Thomas D Bethke. (1998) Cure of Helicobacter pylori infection and healing of duodenal ulcer: comparison of pantoprazole-based one-week modified triple therapy versus two-week dual therapy. American Journal of Gastroenterology 93:10, pages 1919-1924.
Crossref
Crossref
A. T. Prach, M. Malek, M. Tavakoli, D. Hopwood, B. W. Senior & F. E. Murray. (1998)
H
2
-antagonist maintenance therapy versus
Helicobacter pylori
eradication in patients with chronic duodenal ulcer disease: a prospective study
. Alimentary Pharmacology & Therapeutics 12:9, pages 873-880.
Crossref
Crossref
Včev, Včeva, Štimac, Takač, Dmitrović & Kovač. (1998) Omeprazole, azithromycin and either amoxycillin or metronidazole in eradication of Helicobacter pylori in duodenal ulcer patients. Alimentary Pharmacology & Therapeutics 12:5, pages 453-456.
Crossref
Crossref
R J Adamek, S Suerbaum, B Pfaffenbach & W Opferkuch. (1998) Primary and Acquired Helicobacter pylori Resistance to Clarithromycin, Metronidazole, and Amoxicillin—Influence on Treatment Outcome. American Journal of Gastroenterology 93:3, pages 386-389.
Crossref
Crossref
JIA-QING HUANG & RICHARD H HUNT. (1997) Review: Eradication of Helicobacter pylori. Problems and recommendations. Journal of Gastroenterology and Hepatology 12:8, pages 590-598.
Crossref
Crossref
J. Labenz, J.A. Beker, C.P.M. Dekkers, A. Farley, H.‐U. Klör & A. Jönsson. (2003)
Doubling the omeprazole dose (40 mg b.d. vs. 20 mg b.d.) in dual therapy with amoxycillin increases the cure rate of
Helicobacter pylori
infection in duodenal ulcer patients
. Alimentary Pharmacology & Therapeutics 11:3, pages 515-522.
Crossref
Crossref
J. LABENZ, J.-P. IDSTROM, B. TILLENBURG, U. PEITZ, R. J. ADAMEK & G. BORSCH. (1997) One-week low-dose triple therapy for Helicobacter pylori is sufficient for relief from symptoms and healing of duodenal ulcers. Alimentary Pharmacology and Therapeutics 11:1, pages 89-93.
Crossref
Crossref
J. LABENZ, B. TILLENBURG, J. WEISMULLER, A. LUTKE & M. STOLTE. (1997) Efficacy and tolerability of a one-week triple therapy consisting of pantoprazole, clarithromycin and amoxycillin for cure of Helicobacter pylori infection in patients with duodenal ulcer. Alimentary Pharmacology and Therapeutics 11:1, pages 95-100.
Crossref
Crossref
Stephan Miehlke & David Y. Graham. (1997) Antimicrobial therapy of peptic ulcers. International Journal of Antimicrobial Agents 8:3, pages 171-178.
Crossref
Crossref
C Stewart Goodwin, Michael M Mendall & Timothy C Northfield. (1997) Helicobacter pylori infection. The Lancet 349:9047, pages 265-269.
Crossref
Crossref
K. E. L. McColl. (1996) Helicobacter pylori infection and its role in human disease ? an overview. Pharmacy World and Science 18:2, pages 49-55.
Crossref
Crossref
W. A. de Boer & J. G. Penston. (2007) Letters to the Editors. Alimentary Pharmacology & Therapeutics 9:1, pages 85-86.
Crossref
Crossref
Masaru Nasu, Toshio Fujioka & Reiji Kodama. (1995) Helicobacter pylori-Infected Japanese Monkeys. Journal of Infection and Chemotherapy 1:2, pages 90-97.
Crossref
Crossref